NCT03072394

Brief Summary

A randomized clinical trial to test the efficacy of EMLA cream (lidocaine 2.5% and prilocaine 2.5% in a ratio of 1:1 by weight) in comparison to the established local anesthesia (LA) protocol of lidocaine subcutaneous injection, in providing adequate peri-operative local anesthesia during transradial coronary angiography.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
444

participants targeted

Target at P75+ for phase_4

Timeline
Completed

Started Jan 2015

Longer than P75 for phase_4

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 10, 2015

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

February 24, 2017

Completed
11 days until next milestone

First Posted

Study publicly available on registry

March 7, 2017

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 20, 2020

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 10, 2021

Completed
Last Updated

February 28, 2018

Status Verified

February 1, 2018

Enrollment Period

5.9 years

First QC Date

February 24, 2017

Last Update Submit

February 26, 2018

Conditions

Outcome Measures

Primary Outcomes (2)

  • Visual Analog Scale of Pain Perception during sheath insertion

    The primary end-point of the study is the perception of radial pain assessed during artery puncture

    During artery puncture

  • Visual Analog Scale of Pain Perception after sheath removal

    The primary end-point of the study is the perception of radial pain assessed 30 minutes after sheath removal

    30 minutes after sheath removal

Secondary Outcomes (2)

  • Puncture efficiency (number of puncture attempts)

    During radial artery catheterization

  • Radial artery spasm

    During radial artery catheterization

Study Arms (2)

EMLA anesthetic ointment (AO)

EXPERIMENTAL

In AO group a layer of 2.5 gr EMLA cream (standard adult dose) is applied to both wrists, 1 cm above the styloid process of the radius 30 minutes before the puncture, by an experienced cathlab nurse.

Drug: Local anesthetic

Local Skin Anesthetic Injection (LA)

ACTIVE COMPARATOR

In LA group the radial artery is infiltrated with 1-2 mL of 2% lidocaine, using a 26 G needle, 0.5-1 cm proximal to the styloid process one minute before the puncture

Drug: local anaesthetic injection

Interventions

Local skin anesthesia during radial coronary artery catheterization by EMLA anesthetic ointment

Also known as: Local anesthetic ointment
EMLA anesthetic ointment (AO)

Local skin anesthesia during radial coronary artery catheterization by lidocaine injection

Also known as: Skin anethesia by lidocaine injection
Local Skin Anesthetic Injection (LA)

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • referral for elective diagnostic coronary angiography

You may not qualify if:

  • acute coronary syndrome, previous ipsilateral transradial approach, Raynaud's syndrome, abnormal renal function with or without need for hemodialysis, known history of sensitivity to local anesthetics, non-palpable radial pulse, abnormal Barbeau's test and patient's refusal.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hippocration Hospital, Athens University Medical School

Athens, Attica, Greece

RECRUITING

MeSH Terms

Conditions

Coronary Artery Disease

Interventions

Anesthetics, LocalAnesthesia, Local

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Intervention Hierarchy (Ancestors)

AnestheticsCentral Nervous System DepressantsPhysiological Effects of DrugsPharmacologic ActionsChemical Actions and UsesSensory System AgentsPeripheral Nervous System AgentsCentral Nervous System AgentsTherapeutic UsesAnesthesia, ConductionAnesthesiaAnesthesia and Analgesia

Study Officials

  • Dimitris Tousoulis, MD PhD

    Professor of Cardiology

    STUDY DIRECTOR
  • George Latsios, MD PhD

    Consultant Cardiologist

    PRINCIPAL INVESTIGATOR

Central Study Contacts

George Latsios, MD PhD

CONTACT

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Cardiology

Study Record Dates

First Submitted

February 24, 2017

First Posted

March 7, 2017

Study Start

January 10, 2015

Primary Completion

November 20, 2020

Study Completion

January 10, 2021

Last Updated

February 28, 2018

Record last verified: 2018-02

Data Sharing

IPD Sharing
Will not share

Locations